nodes	percent_of_prediction	percent_of_DWPC	metapath
Anidulafungin—Caspofungin—CYP3A4—bone cancer	0.0203	1	CrCbGaD
Anidulafungin—Ventricular extrasystoles—Epirubicin—bone cancer	0.00553	0.00565	CcSEcCtD
Anidulafungin—Blood bilirubin increased—Epirubicin—bone cancer	0.00528	0.00539	CcSEcCtD
Anidulafungin—Hepatobiliary disease—Cisplatin—bone cancer	0.00515	0.00526	CcSEcCtD
Anidulafungin—Ventricular extrasystoles—Doxorubicin—bone cancer	0.00512	0.00523	CcSEcCtD
Anidulafungin—Injection site reaction—Epirubicin—bone cancer	0.00497	0.00507	CcSEcCtD
Anidulafungin—Hyperkalaemia—Epirubicin—bone cancer	0.00491	0.00501	CcSEcCtD
Anidulafungin—Blood bilirubin increased—Doxorubicin—bone cancer	0.00489	0.00499	CcSEcCtD
Anidulafungin—Urinary tract disorder—Cisplatin—bone cancer	0.00483	0.00493	CcSEcCtD
Anidulafungin—Connective tissue disorder—Cisplatin—bone cancer	0.0048	0.0049	CcSEcCtD
Anidulafungin—Urethral disorder—Cisplatin—bone cancer	0.00479	0.00489	CcSEcCtD
Anidulafungin—Candida infection—Epirubicin—bone cancer	0.00477	0.00487	CcSEcCtD
Anidulafungin—Blood urea increased—Epirubicin—bone cancer	0.00472	0.00482	CcSEcCtD
Anidulafungin—Visual impairment—Cisplatin—bone cancer	0.00471	0.00481	CcSEcCtD
Anidulafungin—Sepsis—Methotrexate—bone cancer	0.00463	0.00473	CcSEcCtD
Anidulafungin—Injection site reaction—Doxorubicin—bone cancer	0.0046	0.00469	CcSEcCtD
Anidulafungin—Eye disorder—Cisplatin—bone cancer	0.00457	0.00466	CcSEcCtD
Anidulafungin—Hyperkalaemia—Doxorubicin—bone cancer	0.00454	0.00464	CcSEcCtD
Anidulafungin—Rash maculo-papular—Epirubicin—bone cancer	0.00454	0.00464	CcSEcCtD
Anidulafungin—Cardiac disorder—Cisplatin—bone cancer	0.00454	0.00463	CcSEcCtD
Anidulafungin—Flushing—Cisplatin—bone cancer	0.00454	0.00463	CcSEcCtD
Anidulafungin—Candida infection—Doxorubicin—bone cancer	0.00441	0.00451	CcSEcCtD
Anidulafungin—Immune system disorder—Cisplatin—bone cancer	0.00441	0.00451	CcSEcCtD
Anidulafungin—Mediastinal disorder—Cisplatin—bone cancer	0.0044	0.0045	CcSEcCtD
Anidulafungin—Blood urea increased—Doxorubicin—bone cancer	0.00437	0.00446	CcSEcCtD
Anidulafungin—Sepsis—Epirubicin—bone cancer	0.00434	0.00443	CcSEcCtD
Anidulafungin—Erythema—Cisplatin—bone cancer	0.00425	0.00434	CcSEcCtD
Anidulafungin—Malnutrition—Cisplatin—bone cancer	0.00425	0.00434	CcSEcCtD
Anidulafungin—Phlebitis—Epirubicin—bone cancer	0.00421	0.0043	CcSEcCtD
Anidulafungin—Rash maculo-papular—Doxorubicin—bone cancer	0.0042	0.00429	CcSEcCtD
Anidulafungin—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.00417	0.00426	CcSEcCtD
Anidulafungin—Visual disturbance—Methotrexate—bone cancer	0.00409	0.00418	CcSEcCtD
Anidulafungin—Eye pain—Epirubicin—bone cancer	0.00402	0.0041	CcSEcCtD
Anidulafungin—Sepsis—Doxorubicin—bone cancer	0.00401	0.0041	CcSEcCtD
Anidulafungin—Vision blurred—Cisplatin—bone cancer	0.00401	0.00409	CcSEcCtD
Anidulafungin—Cerebrovascular accident—Methotrexate—bone cancer	0.00396	0.00404	CcSEcCtD
Anidulafungin—Anaemia—Cisplatin—bone cancer	0.00393	0.00401	CcSEcCtD
Anidulafungin—Phlebitis—Doxorubicin—bone cancer	0.0039	0.00398	CcSEcCtD
Anidulafungin—Hot flush—Epirubicin—bone cancer	0.00388	0.00396	CcSEcCtD
Anidulafungin—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.00386	0.00394	CcSEcCtD
Anidulafungin—Menopausal symptoms—Epirubicin—bone cancer	0.00384	0.00392	CcSEcCtD
Anidulafungin—Leukopenia—Cisplatin—bone cancer	0.00381	0.00389	CcSEcCtD
Anidulafungin—Eye pain—Doxorubicin—bone cancer	0.00372	0.0038	CcSEcCtD
Anidulafungin—Hypoglycaemia—Epirubicin—bone cancer	0.00372	0.00379	CcSEcCtD
Anidulafungin—Cerebrovascular accident—Epirubicin—bone cancer	0.0037	0.00378	CcSEcCtD
Anidulafungin—Convulsion—Cisplatin—bone cancer	0.00369	0.00376	CcSEcCtD
Anidulafungin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.0036	0.00367	CcSEcCtD
Anidulafungin—Hot flush—Doxorubicin—bone cancer	0.00359	0.00366	CcSEcCtD
Anidulafungin—Liver function test abnormal—Methotrexate—bone cancer	0.00358	0.00365	CcSEcCtD
Anidulafungin—Menopausal symptoms—Doxorubicin—bone cancer	0.00356	0.00363	CcSEcCtD
Anidulafungin—Anaphylactic shock—Cisplatin—bone cancer	0.00347	0.00354	CcSEcCtD
Anidulafungin—Infection—Cisplatin—bone cancer	0.00345	0.00352	CcSEcCtD
Anidulafungin—Hypoglycaemia—Doxorubicin—bone cancer	0.00344	0.00351	CcSEcCtD
Anidulafungin—Cerebrovascular accident—Doxorubicin—bone cancer	0.00343	0.0035	CcSEcCtD
Anidulafungin—Nervous system disorder—Cisplatin—bone cancer	0.0034	0.00348	CcSEcCtD
Anidulafungin—Thrombocytopenia—Cisplatin—bone cancer	0.0034	0.00347	CcSEcCtD
Anidulafungin—Blood creatinine increased—Epirubicin—bone cancer	0.0034	0.00347	CcSEcCtD
Anidulafungin—Dehydration—Epirubicin—bone cancer	0.00337	0.00344	CcSEcCtD
Anidulafungin—Skin disorder—Cisplatin—bone cancer	0.00337	0.00344	CcSEcCtD
Anidulafungin—Hyperhidrosis—Cisplatin—bone cancer	0.00336	0.00343	CcSEcCtD
Anidulafungin—Liver function test abnormal—Epirubicin—bone cancer	0.00335	0.00342	CcSEcCtD
Anidulafungin—Abdominal pain upper—Epirubicin—bone cancer	0.00331	0.00338	CcSEcCtD
Anidulafungin—Hypokalaemia—Epirubicin—bone cancer	0.0033	0.00337	CcSEcCtD
Anidulafungin—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.00327	0.00333	CcSEcCtD
Anidulafungin—Hypotension—Cisplatin—bone cancer	0.00324	0.00331	CcSEcCtD
Anidulafungin—Alanine aminotransferase increased—Epirubicin—bone cancer	0.0032	0.00327	CcSEcCtD
Anidulafungin—Blood creatinine increased—Doxorubicin—bone cancer	0.00314	0.00321	CcSEcCtD
Anidulafungin—Neutropenia—Methotrexate—bone cancer	0.00313	0.0032	CcSEcCtD
Anidulafungin—Dehydration—Doxorubicin—bone cancer	0.00312	0.00319	CcSEcCtD
Anidulafungin—Liver function test abnormal—Doxorubicin—bone cancer	0.0031	0.00316	CcSEcCtD
Anidulafungin—Dyspnoea—Cisplatin—bone cancer	0.0031	0.00316	CcSEcCtD
Anidulafungin—Abdominal pain upper—Doxorubicin—bone cancer	0.00307	0.00313	CcSEcCtD
Anidulafungin—Hypokalaemia—Doxorubicin—bone cancer	0.00305	0.00312	CcSEcCtD
Anidulafungin—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00302	0.00309	CcSEcCtD
Anidulafungin—Pneumonia—Methotrexate—bone cancer	0.003	0.00307	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Cisplatin—bone cancer	0.003	0.00306	CcSEcCtD
Anidulafungin—Infestation NOS—Methotrexate—bone cancer	0.00299	0.00305	CcSEcCtD
Anidulafungin—Infestation—Methotrexate—bone cancer	0.00299	0.00305	CcSEcCtD
Anidulafungin—Depression—Methotrexate—bone cancer	0.00298	0.00304	CcSEcCtD
Anidulafungin—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00296	0.00302	CcSEcCtD
Anidulafungin—Neutropenia—Epirubicin—bone cancer	0.00293	0.00299	CcSEcCtD
Anidulafungin—Feeling abnormal—Cisplatin—bone cancer	0.00286	0.00292	CcSEcCtD
Anidulafungin—Hyperglycaemia—Epirubicin—bone cancer	0.00283	0.00289	CcSEcCtD
Anidulafungin—Hepatobiliary disease—Methotrexate—bone cancer	0.00283	0.00288	CcSEcCtD
Anidulafungin—Pneumonia—Epirubicin—bone cancer	0.00281	0.00287	CcSEcCtD
Anidulafungin—Infestation—Epirubicin—bone cancer	0.0028	0.00285	CcSEcCtD
Anidulafungin—Infestation NOS—Epirubicin—bone cancer	0.0028	0.00285	CcSEcCtD
Anidulafungin—Body temperature increased—Cisplatin—bone cancer	0.00274	0.0028	CcSEcCtD
Anidulafungin—Urinary tract infection—Epirubicin—bone cancer	0.00272	0.00277	CcSEcCtD
Anidulafungin—Neutropenia—Doxorubicin—bone cancer	0.00271	0.00277	CcSEcCtD
Anidulafungin—Urinary tract disorder—Methotrexate—bone cancer	0.00265	0.0027	CcSEcCtD
Anidulafungin—Hepatobiliary disease—Epirubicin—bone cancer	0.00264	0.0027	CcSEcCtD
Anidulafungin—Urethral disorder—Methotrexate—bone cancer	0.00263	0.00268	CcSEcCtD
Anidulafungin—Hyperglycaemia—Doxorubicin—bone cancer	0.00262	0.00267	CcSEcCtD
Anidulafungin—Pneumonia—Doxorubicin—bone cancer	0.0026	0.00266	CcSEcCtD
Anidulafungin—Infestation—Doxorubicin—bone cancer	0.00259	0.00264	CcSEcCtD
Anidulafungin—Infestation NOS—Doxorubicin—bone cancer	0.00259	0.00264	CcSEcCtD
Anidulafungin—Visual impairment—Methotrexate—bone cancer	0.00258	0.00264	CcSEcCtD
Anidulafungin—Hypersensitivity—Cisplatin—bone cancer	0.00256	0.00261	CcSEcCtD
Anidulafungin—Urinary tract infection—Doxorubicin—bone cancer	0.00251	0.00257	CcSEcCtD
Anidulafungin—Eye disorder—Methotrexate—bone cancer	0.00251	0.00256	CcSEcCtD
Anidulafungin—Cardiac disorder—Methotrexate—bone cancer	0.00249	0.00254	CcSEcCtD
Anidulafungin—Urinary tract disorder—Epirubicin—bone cancer	0.00248	0.00253	CcSEcCtD
Anidulafungin—Oedema peripheral—Epirubicin—bone cancer	0.00247	0.00252	CcSEcCtD
Anidulafungin—Connective tissue disorder—Epirubicin—bone cancer	0.00247	0.00252	CcSEcCtD
Anidulafungin—Urethral disorder—Epirubicin—bone cancer	0.00246	0.00251	CcSEcCtD
Anidulafungin—Hepatobiliary disease—Doxorubicin—bone cancer	0.00245	0.0025	CcSEcCtD
Anidulafungin—Angiopathy—Methotrexate—bone cancer	0.00243	0.00248	CcSEcCtD
Anidulafungin—Immune system disorder—Methotrexate—bone cancer	0.00242	0.00247	CcSEcCtD
Anidulafungin—Visual impairment—Epirubicin—bone cancer	0.00242	0.00247	CcSEcCtD
Anidulafungin—Mediastinal disorder—Methotrexate—bone cancer	0.00242	0.00247	CcSEcCtD
Anidulafungin—Chills—Methotrexate—bone cancer	0.00241	0.00246	CcSEcCtD
Anidulafungin—Diarrhoea—Cisplatin—bone cancer	0.00238	0.00242	CcSEcCtD
Anidulafungin—Mental disorder—Methotrexate—bone cancer	0.00235	0.0024	CcSEcCtD
Anidulafungin—Eye disorder—Epirubicin—bone cancer	0.00235	0.00239	CcSEcCtD
Anidulafungin—Erythema—Methotrexate—bone cancer	0.00233	0.00238	CcSEcCtD
Anidulafungin—Malnutrition—Methotrexate—bone cancer	0.00233	0.00238	CcSEcCtD
Anidulafungin—Cardiac disorder—Epirubicin—bone cancer	0.00233	0.00238	CcSEcCtD
Anidulafungin—Flushing—Epirubicin—bone cancer	0.00233	0.00238	CcSEcCtD
Anidulafungin—Urinary tract disorder—Doxorubicin—bone cancer	0.00229	0.00234	CcSEcCtD
Anidulafungin—Oedema peripheral—Doxorubicin—bone cancer	0.00229	0.00233	CcSEcCtD
Anidulafungin—Connective tissue disorder—Doxorubicin—bone cancer	0.00228	0.00233	CcSEcCtD
Anidulafungin—Angiopathy—Epirubicin—bone cancer	0.00228	0.00232	CcSEcCtD
Anidulafungin—Urethral disorder—Doxorubicin—bone cancer	0.00228	0.00232	CcSEcCtD
Anidulafungin—Immune system disorder—Epirubicin—bone cancer	0.00227	0.00231	CcSEcCtD
Anidulafungin—Mediastinal disorder—Epirubicin—bone cancer	0.00226	0.00231	CcSEcCtD
Anidulafungin—Back pain—Methotrexate—bone cancer	0.00226	0.0023	CcSEcCtD
Anidulafungin—Chills—Epirubicin—bone cancer	0.00225	0.0023	CcSEcCtD
Anidulafungin—Visual impairment—Doxorubicin—bone cancer	0.00224	0.00228	CcSEcCtD
Anidulafungin—Vomiting—Cisplatin—bone cancer	0.00221	0.00225	CcSEcCtD
Anidulafungin—Vision blurred—Methotrexate—bone cancer	0.0022	0.00225	CcSEcCtD
Anidulafungin—Mental disorder—Epirubicin—bone cancer	0.0022	0.00224	CcSEcCtD
Anidulafungin—Rash—Cisplatin—bone cancer	0.00219	0.00223	CcSEcCtD
Anidulafungin—Dermatitis—Cisplatin—bone cancer	0.00219	0.00223	CcSEcCtD
Anidulafungin—Erythema—Epirubicin—bone cancer	0.00218	0.00223	CcSEcCtD
Anidulafungin—Malnutrition—Epirubicin—bone cancer	0.00218	0.00223	CcSEcCtD
Anidulafungin—Eye disorder—Doxorubicin—bone cancer	0.00217	0.00221	CcSEcCtD
Anidulafungin—Anaemia—Methotrexate—bone cancer	0.00216	0.0022	CcSEcCtD
Anidulafungin—Flushing—Doxorubicin—bone cancer	0.00215	0.0022	CcSEcCtD
Anidulafungin—Cardiac disorder—Doxorubicin—bone cancer	0.00215	0.0022	CcSEcCtD
Anidulafungin—Back pain—Epirubicin—bone cancer	0.00211	0.00216	CcSEcCtD
Anidulafungin—Angiopathy—Doxorubicin—bone cancer	0.00211	0.00215	CcSEcCtD
Anidulafungin—Immune system disorder—Doxorubicin—bone cancer	0.0021	0.00214	CcSEcCtD
Anidulafungin—Mediastinal disorder—Doxorubicin—bone cancer	0.00209	0.00214	CcSEcCtD
Anidulafungin—Leukopenia—Methotrexate—bone cancer	0.00209	0.00213	CcSEcCtD
Anidulafungin—Chills—Doxorubicin—bone cancer	0.00208	0.00213	CcSEcCtD
Anidulafungin—Nausea—Cisplatin—bone cancer	0.00206	0.00211	CcSEcCtD
Anidulafungin—Vision blurred—Epirubicin—bone cancer	0.00206	0.0021	CcSEcCtD
Anidulafungin—Cough—Methotrexate—bone cancer	0.00204	0.00208	CcSEcCtD
Anidulafungin—Mental disorder—Doxorubicin—bone cancer	0.00203	0.00208	CcSEcCtD
Anidulafungin—Convulsion—Methotrexate—bone cancer	0.00202	0.00206	CcSEcCtD
Anidulafungin—Erythema—Doxorubicin—bone cancer	0.00202	0.00206	CcSEcCtD
Anidulafungin—Malnutrition—Doxorubicin—bone cancer	0.00202	0.00206	CcSEcCtD
Anidulafungin—Anaemia—Epirubicin—bone cancer	0.00202	0.00206	CcSEcCtD
Anidulafungin—Chest pain—Methotrexate—bone cancer	0.00199	0.00203	CcSEcCtD
Anidulafungin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00197	0.00201	CcSEcCtD
Anidulafungin—Leukopenia—Epirubicin—bone cancer	0.00196	0.002	CcSEcCtD
Anidulafungin—Back pain—Doxorubicin—bone cancer	0.00196	0.002	CcSEcCtD
Anidulafungin—Confusional state—Methotrexate—bone cancer	0.00192	0.00196	CcSEcCtD
Anidulafungin—Cough—Epirubicin—bone cancer	0.00191	0.00195	CcSEcCtD
Anidulafungin—Anaphylactic shock—Methotrexate—bone cancer	0.00191	0.00194	CcSEcCtD
Anidulafungin—Vision blurred—Doxorubicin—bone cancer	0.0019	0.00194	CcSEcCtD
Anidulafungin—Convulsion—Epirubicin—bone cancer	0.00189	0.00193	CcSEcCtD
Anidulafungin—Infection—Methotrexate—bone cancer	0.00189	0.00193	CcSEcCtD
Anidulafungin—Hypertension—Epirubicin—bone cancer	0.00189	0.00193	CcSEcCtD
Anidulafungin—Nervous system disorder—Methotrexate—bone cancer	0.00187	0.00191	CcSEcCtD
Anidulafungin—Anaemia—Doxorubicin—bone cancer	0.00187	0.00191	CcSEcCtD
Anidulafungin—Thrombocytopenia—Methotrexate—bone cancer	0.00187	0.0019	CcSEcCtD
Anidulafungin—Chest pain—Epirubicin—bone cancer	0.00186	0.0019	CcSEcCtD
Anidulafungin—Skin disorder—Methotrexate—bone cancer	0.00185	0.00189	CcSEcCtD
Anidulafungin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00185	0.00189	CcSEcCtD
Anidulafungin—Hyperhidrosis—Methotrexate—bone cancer	0.00184	0.00188	CcSEcCtD
Anidulafungin—Leukopenia—Doxorubicin—bone cancer	0.00181	0.00185	CcSEcCtD
Anidulafungin—Confusional state—Epirubicin—bone cancer	0.0018	0.00184	CcSEcCtD
Anidulafungin—Anaphylactic shock—Epirubicin—bone cancer	0.00178	0.00182	CcSEcCtD
Anidulafungin—Hypotension—Methotrexate—bone cancer	0.00178	0.00182	CcSEcCtD
Anidulafungin—Infection—Epirubicin—bone cancer	0.00177	0.00181	CcSEcCtD
Anidulafungin—Cough—Doxorubicin—bone cancer	0.00176	0.0018	CcSEcCtD
Anidulafungin—Convulsion—Doxorubicin—bone cancer	0.00175	0.00179	CcSEcCtD
Anidulafungin—Nervous system disorder—Epirubicin—bone cancer	0.00175	0.00178	CcSEcCtD
Anidulafungin—Thrombocytopenia—Epirubicin—bone cancer	0.00175	0.00178	CcSEcCtD
Anidulafungin—Hypertension—Doxorubicin—bone cancer	0.00175	0.00178	CcSEcCtD
Anidulafungin—Skin disorder—Epirubicin—bone cancer	0.00173	0.00177	CcSEcCtD
Anidulafungin—Hyperhidrosis—Epirubicin—bone cancer	0.00172	0.00176	CcSEcCtD
Anidulafungin—Insomnia—Methotrexate—bone cancer	0.00172	0.00176	CcSEcCtD
Anidulafungin—Chest pain—Doxorubicin—bone cancer	0.00172	0.00176	CcSEcCtD
Anidulafungin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00171	0.00174	CcSEcCtD
Anidulafungin—Dyspnoea—Methotrexate—bone cancer	0.0017	0.00173	CcSEcCtD
Anidulafungin—Dyspepsia—Methotrexate—bone cancer	0.00168	0.00171	CcSEcCtD
Anidulafungin—Hypotension—Epirubicin—bone cancer	0.00167	0.0017	CcSEcCtD
Anidulafungin—Confusional state—Doxorubicin—bone cancer	0.00166	0.0017	CcSEcCtD
Anidulafungin—Anaphylactic shock—Doxorubicin—bone cancer	0.00165	0.00168	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Methotrexate—bone cancer	0.00164	0.00168	CcSEcCtD
Anidulafungin—Infection—Doxorubicin—bone cancer	0.00164	0.00167	CcSEcCtD
Anidulafungin—Nervous system disorder—Doxorubicin—bone cancer	0.00162	0.00165	CcSEcCtD
Anidulafungin—Thrombocytopenia—Doxorubicin—bone cancer	0.00162	0.00165	CcSEcCtD
Anidulafungin—Insomnia—Epirubicin—bone cancer	0.00161	0.00165	CcSEcCtD
Anidulafungin—Skin disorder—Doxorubicin—bone cancer	0.0016	0.00164	CcSEcCtD
Anidulafungin—Hyperhidrosis—Doxorubicin—bone cancer	0.00159	0.00163	CcSEcCtD
Anidulafungin—Dyspnoea—Epirubicin—bone cancer	0.00159	0.00162	CcSEcCtD
Anidulafungin—Feeling abnormal—Methotrexate—bone cancer	0.00157	0.0016	CcSEcCtD
Anidulafungin—Dyspepsia—Epirubicin—bone cancer	0.00157	0.0016	CcSEcCtD
Anidulafungin—Gastrointestinal pain—Methotrexate—bone cancer	0.00156	0.00159	CcSEcCtD
Anidulafungin—Hypotension—Doxorubicin—bone cancer	0.00154	0.00157	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Epirubicin—bone cancer	0.00154	0.00157	CcSEcCtD
Anidulafungin—Constipation—Epirubicin—bone cancer	0.00152	0.00156	CcSEcCtD
Anidulafungin—Urticaria—Methotrexate—bone cancer	0.00151	0.00154	CcSEcCtD
Anidulafungin—Abdominal pain—Methotrexate—bone cancer	0.00151	0.00154	CcSEcCtD
Anidulafungin—Body temperature increased—Methotrexate—bone cancer	0.00151	0.00154	CcSEcCtD
Anidulafungin—Insomnia—Doxorubicin—bone cancer	0.00149	0.00152	CcSEcCtD
Anidulafungin—Dyspnoea—Doxorubicin—bone cancer	0.00147	0.0015	CcSEcCtD
Anidulafungin—Feeling abnormal—Epirubicin—bone cancer	0.00147	0.0015	CcSEcCtD
Anidulafungin—Gastrointestinal pain—Epirubicin—bone cancer	0.00146	0.00149	CcSEcCtD
Anidulafungin—Dyspepsia—Doxorubicin—bone cancer	0.00145	0.00148	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00142	0.00145	CcSEcCtD
Anidulafungin—Urticaria—Epirubicin—bone cancer	0.00142	0.00145	CcSEcCtD
Anidulafungin—Constipation—Doxorubicin—bone cancer	0.00141	0.00144	CcSEcCtD
Anidulafungin—Abdominal pain—Epirubicin—bone cancer	0.00141	0.00144	CcSEcCtD
Anidulafungin—Body temperature increased—Epirubicin—bone cancer	0.00141	0.00144	CcSEcCtD
Anidulafungin—Hypersensitivity—Methotrexate—bone cancer	0.0014	0.00143	CcSEcCtD
Anidulafungin—Feeling abnormal—Doxorubicin—bone cancer	0.00136	0.00139	CcSEcCtD
Anidulafungin—Gastrointestinal pain—Doxorubicin—bone cancer	0.00135	0.00138	CcSEcCtD
Anidulafungin—Pruritus—Methotrexate—bone cancer	0.00135	0.00138	CcSEcCtD
Anidulafungin—Hypersensitivity—Epirubicin—bone cancer	0.00131	0.00134	CcSEcCtD
Anidulafungin—Urticaria—Doxorubicin—bone cancer	0.00131	0.00134	CcSEcCtD
Anidulafungin—Abdominal pain—Doxorubicin—bone cancer	0.0013	0.00133	CcSEcCtD
Anidulafungin—Body temperature increased—Doxorubicin—bone cancer	0.0013	0.00133	CcSEcCtD
Anidulafungin—Diarrhoea—Methotrexate—bone cancer	0.0013	0.00133	CcSEcCtD
Anidulafungin—Pruritus—Epirubicin—bone cancer	0.00126	0.00129	CcSEcCtD
Anidulafungin—Dizziness—Methotrexate—bone cancer	0.00126	0.00129	CcSEcCtD
Anidulafungin—Diarrhoea—Epirubicin—bone cancer	0.00122	0.00125	CcSEcCtD
Anidulafungin—Hypersensitivity—Doxorubicin—bone cancer	0.00122	0.00124	CcSEcCtD
Anidulafungin—Vomiting—Methotrexate—bone cancer	0.00121	0.00124	CcSEcCtD
Anidulafungin—Rash—Methotrexate—bone cancer	0.0012	0.00123	CcSEcCtD
Anidulafungin—Dermatitis—Methotrexate—bone cancer	0.0012	0.00123	CcSEcCtD
Anidulafungin—Headache—Methotrexate—bone cancer	0.00119	0.00122	CcSEcCtD
Anidulafungin—Dizziness—Epirubicin—bone cancer	0.00118	0.0012	CcSEcCtD
Anidulafungin—Pruritus—Doxorubicin—bone cancer	0.00117	0.00119	CcSEcCtD
Anidulafungin—Vomiting—Epirubicin—bone cancer	0.00113	0.00116	CcSEcCtD
Anidulafungin—Nausea—Methotrexate—bone cancer	0.00113	0.00116	CcSEcCtD
Anidulafungin—Diarrhoea—Doxorubicin—bone cancer	0.00113	0.00115	CcSEcCtD
Anidulafungin—Rash—Epirubicin—bone cancer	0.00112	0.00115	CcSEcCtD
Anidulafungin—Dermatitis—Epirubicin—bone cancer	0.00112	0.00115	CcSEcCtD
Anidulafungin—Headache—Epirubicin—bone cancer	0.00112	0.00114	CcSEcCtD
Anidulafungin—Dizziness—Doxorubicin—bone cancer	0.00109	0.00111	CcSEcCtD
Anidulafungin—Nausea—Epirubicin—bone cancer	0.00106	0.00108	CcSEcCtD
Anidulafungin—Vomiting—Doxorubicin—bone cancer	0.00105	0.00107	CcSEcCtD
Anidulafungin—Rash—Doxorubicin—bone cancer	0.00104	0.00106	CcSEcCtD
Anidulafungin—Dermatitis—Doxorubicin—bone cancer	0.00104	0.00106	CcSEcCtD
Anidulafungin—Headache—Doxorubicin—bone cancer	0.00103	0.00105	CcSEcCtD
Anidulafungin—Nausea—Doxorubicin—bone cancer	0.00098	0.001	CcSEcCtD
